Inventor · disambiguated record
Heidi Rommelaere
Also filed as: ROMMELAERE HEIDI
10 granted patents·7 pending applications·24 citations·filing 2010–2023
85Inventor score
Files withABLYNX NV11MERCK PATENT GMBH3DE BRABANDERE VERONIQUE1ROMMELAERE HEIDI1SAUNDERS MICHAEL JOHN SCOTT1
Top patents by PatentIndex Score
17 records- 0194US11208476B2Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 28, 2021·12 cites·12 claims
- 0292US11332525B2Polypeptides comprising immunoglobulin single variable domains targeting TNFA and IL-23ABLYNX NV·Filed 2021·Granted May 17, 2022·4 cites·14 claims
- 0389US11897951B2Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-αABLYNX NV·Filed 2021·Granted Feb 13, 2024·3 cites·18 claims
- 0488US11840566B2Methods of treating asthma with polypeptides targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 12, 2023·1 cites·18 claims
- 0580US10829552B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using sameMERCK PATENT GMBH·Filed 2018·Granted Nov 10, 2020·1 cites·14 claims
- 0676US10017568B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using sameROMMELAERE HEIDI·Filed 2012·Granted Jul 10, 2018·3 cites·13 claims
- 0774US12492248B2Methods of treatment utilizing polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 9, 2025·0 cites·17 claims
- 0874US12384840B2Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Aug 12, 2025·0 cites·16 claims
- 0974US2022195031A1Amino acid sequences directed against il-17a, il-17f and/or il-17a/f and polypeptides comprising the sameMERCK PATENT GMBH·Filed 2022·Application pending·0 cites
- 1072US11773159B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using sameMERCK PATENT GMBH·Filed 2020·Granted Oct 3, 2023·0 cites·15 claims
- 1168US2024301049A1Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf alphaABLYNX NV·Filed 2023·Application pending·0 cites
- 1267US2021188965A1Polypeptides comprising immunoglobulin single variable domains targeting il-13 and tslpABLYNX NV·Filed 2020·Application pending·0 cites
- 1363US2021188963A1Polypeptides comprising immunoglobulin single variable domains targeting tnfa and il-23ABLYNX NV·Filed 2020·Application pending·0 cites
- 1456US12509522B2Polypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40LABLYNX NV·Filed 2021·Granted Dec 30, 2025·0 cites·20 claims
- 1550US2021188986A1Polypeptides comprising immunoglobulin single variable domains targeting tnfa and ox40lABLYNX NV·Filed 2020·Application pending·0 cites
- 1635US2013109842A1Amino acid sequences of nanobodies directed against p19 subunit of the heterodimeric cytokine il-23DE BRABANDERE VERONIQUE·Filed 2011·Application pending·0 cites
- 1734US2012264917A1Biparatopic protein constructs directed against il-23SAUNDERS MICHAEL JOHN SCOTT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Heidi Rommelaere files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →